News
Study of COVID treatment Quellor has first patient at Louisville hospital
Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his team successfully treated the the first US patient to participate in a...
continue reading
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients
Congratulations to INmune Bio! Tranquil is proud to be a part of this tremendous effort on enrolling the first patient to this important study. LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”),...
continue reading
Quickest Site Activation
Tranquil Clinical Research was the fastest site activated and quickest site to enroll on a Pivotal COVID clinical trial for a top 20 Pharmaceutical Sponsor.
continue reading
Remote Study Start-up Whitepaper
Worried about your research program stalling due to Covid-19? Tranquil Clinical Research has the solution for safely and successfully starting up your trial during a pandemic. The FDA’s Guidance on Conduct of Clinical Trials during the COVID-19 was recently updated...
continue reading
Tranquil Clinical Research Training Mantra
Improving Clinical Trials by improving the people who work on them. A company may have the most state-of-the-art systems, the best leadership, layers of management but the folks doing the work must know what they are doing, be valued and...
continue reading
Work – Life Balance – Tranquil Style
What does work life balance really mean? At Tranquil Clinical Research we want our employees to know we appreciate them and that means giving them time to do the things they love outside of work. We give our employees a...
continue reading